The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America
Abstract
✓ To test the safety and efficacy of tirilazad mesylate, a nonglucocorticoid 21-aminosteroid, in improving the outcome of patients with aneurysmal subarachnoid hemorrhage (SAH), 902 patients were enrolled in a prospective randomized, double-blind, vehicle-controlled trial at 54 North American neurosurgical centers. Five patients were excluded prior to receiving any study drug. Of 897 patients who received at least one dose of study medication, 300 received a placebo containing a citrate vehicle, 298 received 2 mg/kg per day tirilazad, and 299 received 6 mg/kg per day tirilazad, all administered intravenously beginning within 48 hours of the SAH and continuing through 10 days posthemorrhage. All patients were also treated with orally administered nimodipine. At 3 months post-SAH, there were no significant differences (p < 0.025) among the groups with regard to mortality rate, favorable outcome on the Glasgow Outcome Scale, or employment status. During the first 14 days after the SAH, there were no significant differences among the groups in the incidence or severity of clinically symptomatic or angiographically identifiable cerebral vasospasm. Mortality data stratified by gender and neurological grade on admission (assessed according to a modified World Federation of Neurological Surgeons scale) demonstrated that the men with Grades IV to V had a 33% mortality rate in the vehicle group, 52% in the 2 mg/kg per day tirilazad group (p = 0.29), and 5% in the 6 mg/kg per day tirilazad group (p = 0.03). Tirilazad was well tolerated at both dose levels. Tirilazad mesylate at dosage levels of up to 6 mg/kg per day for 8 to 10 days following SAH did not improve the overall outcome in patients with aneurysmal SAH in this trial. The differences in the efficacy of tirilazad in this trial and a previously reported trial in Europe, Australia, and New Zealand, in which dosage levels of tirilazad of 6 mg/kg per day reduced mortality rates and increased good recovery, may be a result of differences in admission characteristics of the patients and/or differences in management protocols, including the use of anticonvulsant medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Applied Linear Statistical Models
Ziegel, E. R., Neter, J., Wasserman, W., & Kutner, M. (1992) · Technometrics · doi:10.2307/1269588 · Cited by 9,907
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
Measurements of acute cerebral infarction: a clinical examination scale.
Brott, T., Adams, H. P., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., & Hertzberg, V (1989) · Stroke · doi:10.1161/01.str.20.7.864 · Cited by 5,911
Applied linear statistical models : regression, analysis of variance, and experimental designs
Neter, J., Wasserman, W., & Kutner, M. (1974) · Andalas University Repository (Andalas University) · Cited by 2,818
Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.
Lyden, P., Brott, T., Tilley, B., Welch, K. M., Mascha, E. J., Levine, S., Haley, E. C., Grotta, J., & Marler, J. (1994) · Stroke · doi:10.1161/01.str.25.11.2220 · Cited by 1,285
Self-citation(1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.6.0985 · Cited by 1,196
Mayberg, M. R., Batjer, H. H., Dacey, R., Diringer, M., Haley, E. C., Heros, R. C., Sternau, L. L., Torner, J., Adams, H. P., & Feinberg, W. (1994) · Stroke · doi:10.1161/01.str.25.11.2315 · Cited by 715
Self-citationMayberg, M. R., Batjer, H. H., Dacey, R., Diringer, M., Haley, E. C., Heros, R. C., Sternau, L. L., Torner, J., Adams, H. P., & Feinberg, W. (1994) · Circulation · doi:10.1161/01.cir.90.5.2592 · Cited by 510
Self-citationPrognosis of Patients with Severe Head Injury
Jennett, B., Teasdale, G., Braakman, R., Minderhoud, J., Heiden, J., & Kurze, T. (1979) · Neurosurgery · doi:10.1227/00006123-197904000-00001 · Cited by 485
Kassell, N. F., Haley, E. C., Apperson-Hansen, C., Alves, W. M., & _, _. (1996) · Journal of Neurosurgery · doi:10.3171/jns.1996.84.2.0221 · Cited by 394
Self-citationMeasurements of acute cerebral infarction: lesion size by computed tomography.
Brott, T., Marler, J. R., Olinger, C. P., Adams, H. P., Tomsick, T., Barsan, W. G., Biller, J., Eberle, R., Hertzberg, V, & Walker, M. (1989) · Stroke · doi:10.1161/01.str.20.7.871 · Cited by 384
Haley, E. C., Kassell, N. F., Torner, J. C., & _, _. (1993) · Journal of Neurosurgery · doi:10.3171/jns.1993.78.4.0537 · Cited by 351
Self-citationHall, E. D., McCall, J. M., & Means, E. D. (1994) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60497-4 · Cited by 211
Xue, D., Slivka, A. P., & Buchan, A. M. (1992) · Stroke · doi:10.1161/01.str.23.6.894 · Cited by 147
Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage
Haley, E. C., Kassell, N. F., Alves, W. M., Weir, B., Apperson-Hansen, C., & _, _. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.82.5.0786 · Cited by 126
Self-citationEffect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage
Zuccarello, M., Marsch, J. T., Schmitt, G., Woodward, J., & Anderson, D. K. (1989) · Journal of neurosurgery · doi:10.3171/jns.1989.71.1.0098 · Cited by 105
Park, C. K., & Hall, E. D. (1994) · Brain Research · doi:10.1016/0006-8993(94)91649-7 · Cited by 76
Prognosis of patients with severe head injury
Jennett, B., Teasdale, G. M., Braakman, R., Minderhoud, J. M., Heiden, J. S., & Kurze, T. (1979) · Neurosurgery · doi:10.1097/00006123-197904000-00001 · Cited by 65
Fleishaker, J. C., Peters, G. R., & Cathcart, K. S. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03940.x · Cited by 57
The Effect of the 21-Aminosteroid U74006F in a Rabbit Model of Thromboembolic Stroke
Wilson, J. T., Bednar, M. M., McAuliffe, T. L., Raymond, S. J., & Gross, C. E. (1992) · Neurosurgery · doi:10.1097/00006123-199211000-00016 · Cited by 36
Fleishaker, J. C., Peters, G. R., Cathcart, K. S., & Steenwyk, R. C. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03941.x · Cited by 34
Cited by
Connolly, E. S., Rabinstein, A. A., Carhuapoma, J. R., Derdeyn, C. P., Dion, J., Higashida, R. T., Hoh, B. L., Kirkness, C. J., Naidech, A. M., Ogilvy, C. S., et al. (2012) · Stroke · doi:10.1161/str.0b013e3182587839 · Cited by 3,512
Subarachnoid haemorrhage: diagnosis, causes and management
van Gijn, J., & Rinkel, G. J. E. (2001) · Brain · doi:10.1093/brain/124.2.249 · Cited by 1,353
Bederson, J. B., Connolly, E. S., Batjer, H. H., Dacey, R. G., Dion, J. E., Diringer, M. N., Duldner, J. E., Harbaugh, R. E., Patel, A. B., & Rosenwasser, R. H. (2009) · Stroke · doi:10.1161/strokeaha.108.191395 · Cited by 1,189
Prediction of Symptomatic Vasospasmafter Subarachnoid Hemorrhage: The Modified Fisher Scale
Frontera, J. A., Claassen, J., Schmidt, J. M., Wartenberg, K. E., Temes, R., Connolly, E. S., Macdonald, R. L., & Mayer, S. A. (2006) · Neurosurgery · doi:10.1227/01.neu.0000218821.34014.1b · Cited by 844
Metadata
- Authors
- Haley, E. C., Kassell, N. F., Apperson-Hansen, C., Maile, M. H., Alves, W. M., & _, _.
- Venue
- Journal of Neurosurgery
- Published
- 1997-03
- Volume
- 86
- Issue
- 3
- Pages
- 467-474
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W2078080170
- Cited by
- 294
- References
- 24
- FWCI
- 13.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.